Impact of fermentable fibres on the colonic microbiota metabolism of dietary polyphenols rutin and quercetin

International Journal of Environmental Research and Public Health

Volumn 16, Issue 2, 2019, Pages

  Mansoorian, Bahareh ^a   Combet, Emilie ^a   Alkhaldy, Areej ^a   Garcia, Ada L ^a   Ann Edwards, Christine ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Colon; Fermentation; Fibre; Microbiome; Microbiota; Phenolic acids; Polyphenols; Quercetin; Rutin; Short chain fatty acids

Indexed keywords

3 HYDROXY PHENYL ACETIC ACID; 3 HYDROXY PHENYL PROPIONIC ACID; 3,4 DIHYDROXY PHENYL ACETIC ACID; 4 HYDROXY BENZOIC ACID; 4 HYDROXY PHENYL ACETIC ACID; 4 HYDROXY PHENYL PROPIONIC ACID; ACETIC ACID DERIVATIVE; BENZOIC ACID DERIVATIVE; ISPAGULA; PECTIN; PHENYL ACETIC ACID; PROPIONIC ACID DERIVATIVE; QUERCETIN; RUTOSIDE; UNCLASSIFIED DRUG; POLYPHENOL;

BIOTA; DIET; FATTY ACID; FERMENTATION; METABOLISM; PHENOL; PIGMENT;

ADULT; ARTICLE; BACTERIUM CULTURE; BIODEGRADATION; BODY MASS; COLON FLORA; CONTROLLED STUDY; DIETARY FIBER; FEMALE; FERMENTATION; FLAME IONIZATION DETECTION; HUMAN; INCUBATION TIME; LIMIT OF QUANTITATION; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; PH; FECES; INTESTINE FLORA; METABOLISM; YOUNG ADULT;

PLANTAGO OVATA;

ADULT; DIETARY FIBER; FECES; FEMALE; FERMENTATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; POLYPHENOLS; QUERCETIN; RUTIN; YOUNG ADULT;

EID: 85060386300     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph16020292     Document Type: Article

References (47)

1. Jaganath, I.B.; Mullen, W.; Lean, M.E.; Edwards, C.A.; Crozier, A. In vitro catabolism of rutin by human fecal bacteria and the antioxidant capacity of its catabolites. Free Radic. Biol. Med. 2009, 47, 1180–1189. [CrossRef] [PubMed]
2. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747. [CrossRef] [PubMed]
3. Menezes, R.; Rodriguez-Mateos, A.; Kaltsatou, A.; González-Sarrías, A.; Greyling, A.; Giannaki, C.; Andres-Lacueva, C.; Milenkovic, D.; Gibney, E.; Dumont, J. Impact of flavonols on cardiometabolic biomarkers: A meta-analysis of randomized controlled human trials to explore the role of inter-individual variability. Nutrients 2017, 9, 117. [CrossRef] [PubMed]
4. White, M.; Little, C.; Roxburgh, C.; Combet, E. The role of polyphenols in the development of colorectal cancer: A systematic review and meta-analysis of case-controlled studies. Proc. Nutr. Soc. 2014, 73, E13. [CrossRef]
5. ′-glucoside in rats. Drug Metab. Dispos. 2005, 33, 1036–1043. [CrossRef] [PubMed]
6. Ludwig, I.A.; Mena, P.; Calani, L.; Borges, G.; Pereira-Caro, G.; Bresciani, L.; Del Rio, D.; Lean, M.E.; Crozier, A. New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. Free Radic. Biol. Med. 2015, 89, 758–769. [CrossRef]
7. Kim, D.-H.; Jung, E.-A.; Sohng, I.-S.; Han, J.-A.; Kim, T.-H.; Han, M.J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 1998, 21, 17–23. [CrossRef]
8. Monagas, M.; Khan, N.; Andrés-Lacueva, C.; Urpí-Sardá, M.; Vázquez-Agell, M.; Lamuela-Raventós, R.M.; Estruch, R. Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Br. J. Nutr. 2009, 102, 201–206. [CrossRef]
9. Edwards, C.; Havlik, J.; Cong, W.; Mullen, W.; Preston, T.; Morrison, D.; Combet, E. Polyphenols and health: Interactions between fibre, plant polyphenols and the gut microbiota. Nutr. Bull. 2017, 42, 356–360. [CrossRef]
10. Kay, C.D.; Pereira-Caro, G.; Ludwig, I.A.; Clifford, M.N.; Crozier, A. Anthocyanins and flavanones are more bioavailable than previously perceived: A review of recent evidence. Annu. Rev. Food Sci. Technol. 2017, 8, 155–180. [CrossRef]
11. Alkhaldy, A.; Edwards, C.; Combet, E. The effect of ageing on the colonic bacterial metabolism of dietary polyphenols. Proc. Nutr. Soc. 2012, 71, E60. [CrossRef]
12. Pashikanti, S.; de Alba, D.R.; Boissonneault, G.A.; Cervantes-Laurean, D. Rutin metabolites: Novel inhibitors of nonoxidative advanced glycation end products. Free Radic. Biol. Med. 2010, 48, 656–663. [CrossRef] [PubMed]
13. Hollman, P.C.; de Vries, J.H.; van Leeuwen, S.D.; Mengelers, M.J.; Katan, M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62, 1276–1282. [CrossRef] [PubMed]
14. Jaganath, I.B.; Jaganath, I.B.; Mullen, W.; Edwards, C.A.; Crozier, A. The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic. Res. 2006, 40, 1035–1046. [CrossRef]
15. Walle, T.; Otake, Y.; Walle, U.K.; Wilson, F.A. Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J. Nutr. 2000, 130, 2658–2661. [CrossRef] [PubMed]
16. Gibson, G.R.; Fuller, R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J. Nutr. 2000, 130, 391S–395S. [CrossRef]
17. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417–1435. [CrossRef] [PubMed]
18. Kemperman, R.A.; Gross, G.; Mondot, S.; Possemiers, S.; Marzorati, M.; Van de Wiele, T.; Doré, J.; Vaughan, E.E. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Res. Int. 2013, 53, 659–669. [CrossRef]
19. Lee, H.C.; Jenner, A.M.; Low, C.S.; Lee, Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157, 876–884. [CrossRef]
20. Parkar, S.G.; Stevenson, D.E.; Skinner, M.A. The potential influence of fruit polyphenols on colonic microflora and human gut health. Int. J. Food Microbiol. 2008, 124, 295–298. [CrossRef]
21. Tzounis, X.; Rodriguez-Mateos, A.; Vulevic, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am. J. Clin. Nutr. 2011, 93, 62–72. [CrossRef] [PubMed]
22. Tzounis, X.; Vulevic, J.; Kuhnle, G.G.; George, T.; Leonczak, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr. 2008, 99, 782–792. [CrossRef] [PubMed]
23. Shahzad, M.; Millhouse, E.; Culshaw, S.; Edwards, C.A.; Ramage, G.; Combet, E. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation. Food Funct. 2015, 6, 719–729. [CrossRef] [PubMed]
24. Etxeberria, U.; Fernández-Quintela, A.; Milagro, F.I.; Aguirre, L.; Martínez, J.A.; Portillo, M.P. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J. Agric. Food Chem. 2013, 61, 9517–9533. [CrossRef] [PubMed]
25. Palafox-Carlos, H.; Ayala-Zavala, J.F.; González-Aguilar, G.A. The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants. J. Food Sci. 2011, 76, R6–R15. [CrossRef] [PubMed]
26. Edwards, C.; Parrett, M.A. Colonic fermentation-in vitro and in vivo approaches to measurement. Sci. des Aliments 1999, 19, 291–300.
27. Kaur, A.; Rose, D.J.; Rumpagaporn, P.; Patterson, J.A.; Hamaker, B.R. In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using “slowly fermentable” dietary fibers. J. Food Sci. 2011, 76, H137–H142. [CrossRef]
28. Combet, E.; Lean, M.E.; Boyle, J.G.; Crozier, A.; Davidson, D.F. Dietary flavonols contribute to false-positive elevation of homovanillic acid, a marker of catecholamine-secreting tumors. Clin. Chim. Acta 2011, 412, 165–169. [CrossRef]
29. Laurentin, A.; Edwards, C.A. Differential fermentation of glucose-based carbohydrates in vitro by human faecal bacteria. Eur. J. Nutr. 2004, 43, 183–189. [CrossRef]
30. Justesen, U.; Arrigoni, E.; Larsen, B.R.; Amado, R. Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. LWT-Food Sci. Technol. 2000, 33, 424–430. [CrossRef]
31. Aura, A.-M.; O’leary, K.; Williamson, G.; Ojala, M.; Bailey, M.; Puupponen-Pimiä, R.; Nuutila, A.; Oksman-Caldentey, K.-M.; Poutanen, K. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 2002, 50, 1725–1730. [CrossRef] [PubMed]
32. Labib, S.; Erb, A.; Kraus, M.; Wickert, T.; Richling, E. The pig caecum model: A suitable tool to study the intestinal metabolism of flavonoids. Mol. Nutr. Food Res. 2004, 48, 326–332. [CrossRef]
33. Rechner, A.R.; Smith, M.A.; Kuhnle, G.; Gibson, G.R.; Debnam, E.S.; Srai, S.K.S.; Moore, K.P.; Rice-Evans, C.A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212–225. [CrossRef]
34. Mena, P.; Ludwig, I.A.; Tomatis, V.B.; Acharjee, A.; Calani, L.; Rosi, A.; Brighenti, F.; Ray, S.; Griffin, J.L.; Bluck, L.J. Inter-individual variability in the production of flavan-3-ol colonic metabolites: Preliminary elucidation of urinary metabotypes. Eur. J. Nutr. 2018, 1–15. [CrossRef]
35. Sandler, M.; Ruthven, C.; Goodwin, B.; Lees, A.; Stern, G. Phenylacetic acid in human body fluids: High correlation between plasma and cerebrospinal fluid concentration values. J. Neurol. Neurosurg. Psychiatry 1982, 45, 366–368. [CrossRef] [PubMed]
36. Brusilow, S.W. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res. 1991, 29, 147–150. [CrossRef] [PubMed]
37. Hommes, F.A. The assay of phenylacetic acid and 4-phenylbutyric acid in physiological fluids. Clin. Chim. Acta Int. J. Clin. Chem. 1999, 284, 109–111. [CrossRef]
38. Yu, X.; Thompson, M.M.; Shi, D.; Tuchman, M. Quantification of benzoic, phenylacetic, and phenylbutyric acids from filter-paper blood spots by gas chromatography–mass spectrometry with stable isotope dilution. Clin. Chem. 2001, 47, 351–354.
39. Arima, H.; Ashida, H.; Danno, G.-i. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci. Biotechnol. Biochem. 2002, 66, 1009–1014. [CrossRef]
40. Vaquero, M.R.; Alberto, M.; de Nadra, M.M. Antibacterial effect of phenolic compounds from different wines. Food Control 2007, 18, 93–101. [CrossRef]
41. Duda-Chodak, A. The inhibitory effect of polyphenols on human gut microbiota. J. Physiol. Pharmacol. 2012, 63, 497–503. [PubMed]
42. Massot-Cladera, M.; Pérez-Berezo, T.; Franch, A.; Castell, M.; Pérez-Cano, F.J. Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch. Biochem. Biophys. 2012, 527, 105–112. [CrossRef] [PubMed]
43. Crozier, A.; Jaganath, I.B.; Clifford, M.N. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat. Product Rep. 2009, 26, 1001–1043. [CrossRef] [PubMed]
44. Neveu, V.; Perez-Jimenez, J.; Vos, F.; Crespy, V.; Du Chaffaut, L.; Mennen, L.; Knox, C.; Eisner, R.; Cruz, J.; Wishart, D. Phenol-Explorer: An online comprehensive database on polyphenol contents in foods. Database 2010, 2010, bap024. [CrossRef] [PubMed]
45. Pérez-Jiménez, J.; Serrano, J.; Tabernero, M.; Arranz, S.; Díaz-Rubio, M.E.; García-Diz, L.; Goñi, I.; Saura-Calixto, F. Bioavailability of phenolic antioxidants associated with dietary fiber: Plasma antioxidant capacity after acute and long-term intake in humans. Plant Foods Hum. Nutr. 2009, 64, 102–107. [CrossRef] [PubMed]
46. Turnbaugh, P.J.; Ley, R.E.; Hamady, M.; Fraser-Liggett, C.M.; Knight, R.; Gordon, J.I. The human microbiome project. Nature 2007, 449, 804. [CrossRef]
47. Greenhill, C. Gut microbiota: Anti-cancer therapies affected by gut microbiota. Nature Rev. Gastroenterol. Hepatol. 2013, 11, 1. [CrossRef] [PubMed]